Vested interests in healthcare, as usual

Amy Wang and colleagues from Mayo Clinic write about the tendancy for authors with financial ties to GlaxoSmithKline to write favourably about the drug Rosiglitazone, which has been linked to increased risk of myocardial function and is arguably less useful than another drug on the market, Pioglitazone. Both drugs are used in diabetes care. Fiona … Continue reading Vested interests in healthcare, as usual